Year archive

Abliva — 2014 filings

All 61 regulatory filings released by Abliva (ABLI) in 2014, sourced directly from the official regulator.

61 Filings

2014 Period

2014 filings (61)

Filing	Released	Lang
NeuroVive har anställt en Clinical Trial Manager Board/Management Information	2014-12-08	Swedish
NeuroVive employs a Clinical Trial Manager Board/Management Information	2014-12-08	English
NeuroVive and Skåne University Hospital initiate collaboration on clinical phase II study on kidney protection during heart surgery Earnings Release FY 2014	2014-12-02	English
NeuroVive och Skånes universitetssjukhus inleder samarbete kring klinisk fas II-studie för njurskydd i samband med hjärtoperation Earnings Release FY 2014	2014-12-02	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report 9M 2014	2014-11-19	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report 9M 2014	2014-11-19	English
Annual General Meeting 2015 and information about members appointed to the Nomination Committee AGM Information	2014-10-29	English
Årsstämma 2015 och information om utsedda ledamöter till valberedningen AGM Information	2014-10-29	Swedish
Addendum: OnCore License M&A Activity	2014-09-11	English
Ytterligare information om licensavtalet med OnCore Regulatory Filings	2014-09-11	Swedish
NeuroVive signs USD 150 m agreement with OnCore BioPharma for the outlicensing of NVP018 for the treatment of chronic Hepatitis B virus infection M&A Activity	2014-09-09	English
NeuroVive tecknar miljardavtal med OnCore BioPharma för utlicensiering av NVP018 inom behandling av kronisk hepatit B-infektion Regulatory Filings	2014-09-09	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report H1 2014	2014-08-20	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report H1 2014	2014-08-20	English
Audit Report / Information 2013 Audit Report / Information FY 2013	2014-08-20	Swedish
Annual Report 2013 Annual Report FY 2013	2014-08-20	English
Enrollment to phase II study on NeuroSTAT® continues Regulatory Filings	2014-08-14	English
Fortsatt rekrytering till klinisk fas II-studie med NeuroSTAT® Regulatory Filings	2014-08-14	Swedish
NeuroVive’s research into energy regulation wins award at international research symposium Regulatory Filings	2014-06-10	English
Forskning om NeuroVives energireglerare prisbelönt vid internationell forskningskonferens Regulatory Filings	2014-06-10	Swedish
NeuroVive tecknar nytt avtal med Hospices Civils de Lyon Regulatory Filings	2014-06-04	Swedish
NeuroVive signs new agreement with Hospices Civils de Lyon Regulatory Filings	2014-06-04	English
Report from AGM AGM Information	2014-05-09	English
Kommuniké från årsstämma AGM Information	2014-05-09	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-09	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-09	English
NeuroVive presenterar medicinskt genombrott inom energireglering på cellnivå Regulatory Filings	2014-04-17	Swedish
NeuroVive presents medical breakthrough in cellular energy regulation Regulatory Filings	2014-04-17	English
NeuroVives aktie handlas nu även på OTC-marknaden i USA Regulatory Filings	2014-04-10	Swedish
NeuroVive Stock Now Trading in the USA on the OTC Market Regulatory Filings	2014-04-10	English
Invitation to the AGM of NeuroVive Pharmaceutical AB (publ) AGM Information	2014-04-09	English
Kallelse till årsstämma i NeuroVive Pharmaceutical AB (publ) AGM Information	2014-04-09	Swedish
Major Shareholding Notification 2014 Major Shareholding Notification	2014-04-04	English
Ökat individuellt ägande genom överföring av aktier från Maas Biolab, LLC Share Issue/Capital Change	2014-03-31	Swedish
Increased individual ownership through share exchange from Maas Biolab, LLC Major Shareholding Notification	2014-03-31	English
NeuroVive presenterar övertygande hepatit B data för sin läkemedelskandidat NVP018 Earnings Release FY 2014	2014-03-28	Swedish
NeuroVive presents significant hepatitis B data for its drug candidate NVP018 Regulatory Filings	2014-03-28	English
NeuroVive Pharmaceutical och A1M Pharma inleder forskningssamarbete M&A Activity	2014-03-25	Swedish
NeuroVive Pharmaceutical and A1M Pharma initiate research collaboration Regulatory Filings	2014-03-25	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-03-21	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-03-14	English
Ändring av antal aktier och röster i NeuroVive Pharmaceutical AB Declaration of Voting Results & Voting Rights Announcements	2014-03-13	Swedish
NeuroVive inleder samarbete i syfte att utvärdera notering av dotterbolag i Taiwan Share Issue/Capital Change	2014-03-10	Swedish
NeuroVive starts collaboration to evaluate IPO of subsidiary in Taiwan Delisting Announcement	2014-03-10	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-02-25	English
Interim / Quarterly Report 2013 Interim / Quarterly Report FY 2013	2014-02-19	Swedish
Annual Report 2013 Annual Report FY 2013	2014-02-19	English
NeuroVive treats final patient in European phase III trial on CicloMulsion® Legal Proceedings Report	2014-02-17	English
NeuroVive har behandlat sista patienten i europeisk fas III-studie med CicloMulsion® Regulatory Filings	2014-02-17	Swedish
Major Shareholding Notification 2014 Major Shareholding Notification	2014-02-11	English
Företrädesemissionen i NeuroVive övertecknad med 270 procent Share Issue/Capital Change	2014-01-31	Swedish
NeuroVive rights issue 270% oversubscribed Capital/Financing Update	2014-01-31	English
NeuroVive utökar samarbetet med inVentiv Health inför kommande marknadslansering Regulatory Filings	2014-01-29	Swedish
NeuroVive extends partnership agreement with InVentiv Health to prepare for upcoming market launch Regulatory Filings	2014-01-29	English
Supplementary subscription undertakings by transfer of subscription rights Capital/Financing Update	2014-01-23	English
Kompletterande teckningsåtaganden genom övertagande av teckningsrätter Capital/Financing Update	2014-01-23	Swedish
Sista handelsdag för teckningsrätter i pågående företrädesemission Capital/Financing Update	2014-01-22	Swedish
Senior managers’ and Directors’ subscriptions in new issue Share Issue/Capital Change	2014-01-15	English
Teckning i nyemission av ledande befattningshavare och styrelseledamöter Share Issue/Capital Change	2014-01-15	Swedish
NeuroVive Pharmaceutical AB (publ) publishes prospectus Share Issue/Capital Change	2014-01-08	English
NeuroVive Pharmaceutical AB (publ) offentliggör prospekt Capital/Financing Update	2014-01-08	Swedish

Filings by year

2025 11 filings
2024 38 filings
2023 23 filings
2022 38 filings
2021 40 filings
2020 43 filings
2019 45 filings
2018 57 filings
2017 63 filings
2016 72 filings
2015 68 filings
2014 61 filings
2013 35 filings